Oncologic Diseases
Conditions
Keywords
18-f FDG PET/CT
Brief summary
To evaluate implications of biological and procedural factors of 18-f FDG PET/CT uptake on normal organs and neoplastic lesions.
Detailed description
18-f FDG is used on oncological patients undergoing PET/CT study at our nuclear medicine unit , its uptake by the tissues depends on glucose blood level and consumption then we evaluate the implications of biological and procedural factors on the uptake by normal organs and neoplastic lesions using standardized uptake values SUVmax , mean and peak.
Interventions
RADIATION18 FDG (Fludeoxyglucose 18F)
18-f FDG
Sponsors
mahenoor alaa eldeen naem
Study design
Observational model
COHORT
Time perspective
CROSS_SECTIONAL
Eligibility
Sex/Gender
ALL
Age
1 Years to 90 Years
Healthy volunteers
No
Inclusion criteria
* cancer patients referred to nuclear medicine unit
Exclusion criteria
* patients with increased FDG uptake associated with non malignant causes such as diffuse bone marrow FDG uptake or lung infection or patients with extensive metastasis in target organs
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| PET/CT scan on cancer patient will be performed to evaluate the biological and procedural factors of 18-f FDG uptake by multiple normal organs and neoplastic lesions using Standardized uptake values | 2 years | SUV mean , suv peak and suv max |
Countries
Egypt
Contacts
Primary ContactMahenoor Alaa Abouelouon, Master
Backup Contactnadia mohany mostafa, assistant professor
Outcome results
None listed